PhD in Biology from the University of Gottingen, Germany; Postdoctoral fellows at Southwestern Medical School and Memorial Sloan Kettering Cancer Center in New York, USA; I have worked for over 20 years in multiple multinational pharmaceutical companies in the United States, including Wyeth/Pfizer, P&G Pharmaceuticals, Allergan/AbbVie, and Corbus Pharmaceuticals. I have been involved in the development and management of new drugs in the fields of autoimmune/inflammatory diseases, metabolic disorders, tumors, and digestive tract diseases; Published 50 research papers in top international journals such as Nature, Cell, Lancet, etc; Participated in and led the NDA application, approval, and marketing of multiple innovative drugs in the United States, Europe, Canada, and China. Current Chairman of Fujian Guangsheng Zhonglin Biotechnology Co., Ltd.